share_log

鲁抗医药2024年半年度报告

Shandong Lukang Pharmaceutical's 2024 half-year report

SZSI ·  Aug 21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more